Johnson & Johnson
JNJ
$193.22
$1.100.57%
NYSE
09/30/2025 | 06/29/2025 | 03/30/2025 | 12/29/2024 | 09/29/2024 | |
---|---|---|---|---|---|
Revenue | 5.08% | 4.68% | 4.30% | 4.30% | 4.77% |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 5.08% | 4.68% | 4.30% | 4.30% | 4.77% |
Cost of Revenue | 8.86% | 8.77% | 7.59% | 4.77% | 5.01% |
Gross Profit | 3.42% | 2.90% | 2.88% | 4.09% | 4.67% |
SG&A Expenses | 6.34% | 5.93% | 6.55% | 9.27% | 8.78% |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 4.74% | 8.99% | 8.14% | 8.53% | 8.52% |
Operating Income | 6.01% | -6.41% | -5.64% | -6.53% | -4.45% |
Income Before Tax | 78.72% | 40.21% | 32.60% | 10.79% | 25.22% |
Income Tax Expenses | 123.26% | 50.05% | 60.28% | 50.98% | 72.75% |
Earnings from Continuing Operations | 70.10% | 38.33% | 27.75% | 5.55% | 18.89% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -100.37% |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | 71.06% | -40.39% | -43.32% | -59.99% | -57.59% |
EBIT | 6.01% | -6.41% | -5.64% | -6.53% | -4.45% |
EBITDA | 6.79% | -3.15% | -3.52% | -4.27% | -3.06% |
EPS Basic | 77.21% | -37.70% | -40.18% | -57.61% | -56.89% |
Normalized Basic EPS | 2.98% | -3.79% | 1.13% | 2.27% | 11.81% |
EPS Diluted | 77.41% | -37.41% | -39.94% | -57.43% | -56.62% |
Normalized Diluted EPS | 3.08% | -3.47% | 1.55% | 2.39% | 12.25% |
Average Basic Shares Outstanding | -3.40% | -4.32% | -6.09% | -7.85% | -3.31% |
Average Diluted Shares Outstanding | -3.46% | -4.63% | -6.47% | -7.97% | -3.81% |
Dividend Per Share | 4.53% | 4.37% | 4.20% | 4.47% | 4.74% |
Payout Ratio | -0.55% | 1.33% | 1.39% | 2.32% | 2.07% |